Keyphrases
Randomized Controlled Trial
86%
Polycystic Ovary Syndrome
86%
Anovulatory Infertility
86%
Live Birth Rate
85%
Cell Division
72%
Abnormal Cells
72%
Live Birth
71%
Ovarian Hyperstimulation Syndrome
68%
Infertile Women
60%
Gonadotropins
49%
Follicle
47%
Blastocyst Transfer
46%
Denmark
43%
IVF Patients
43%
Granulosa Cells
43%
Prospective Randomized Trial
43%
Transcriptome
43%
Stimulation Cycle
43%
Ovulation
43%
Assisted Reproductive Technology
43%
Merck
43%
Ovarian Response
43%
Human Chorionic Gonadotropin Trigger
43%
Gonadotropin-releasing Hormone Agonist Trigger
43%
Blastomere
43%
GnRH Agonist Trigger
43%
Controlled Ovarian Stimulation
43%
Luteal Phase
43%
Cardiovascular Risk
43%
Number of Births
43%
Weight Control
43%
Revised Criteria
43%
Weight Reduction
43%
Ovulation Induction
43%
Blastocyst
43%
Prospective Observational Study
43%
WHO Group
43%
Sweden
41%
Obese Women
36%
Human Chorionic Gonadotropin
36%
Ovulatory
33%
Insulin Resistance
32%
Starting Dose
32%
Frozen Embryo Transfer
28%
Fresh Embryo Transfer
28%
Natural Cycle
25%
Weight Loss
24%
Antral Follicle Count
23%
Gonadotropin-releasing Hormone
23%
Mature Follicles
21%
Medicine and Dentistry
Randomized Controlled Trial
100%
Polycystic Ovary Syndrome
86%
Follicle
80%
Chorionic Gonadotropin
69%
Body Mass Index
62%
Ovarian Hyperstimulation Syndrome
60%
Gonadotropin
52%
Antral Follicle
52%
Gonadorelin Agonist
48%
Ovulation
44%
Gonadotropin-Releasing Hormone
43%
Hypothalamic Amenorrhea
43%
Granulosa Cell
43%
Birth Rate
43%
Assisted Reproductive Technology
43%
Embryo Transfer
43%
Transcriptome
43%
Cardiovascular Risk
43%
Luteal Phase
43%
Observational Study
43%
Ovulation Induction
43%
Blastocyst
26%
Prevalence
21%
Pregnancy Rate
18%
Parthenogenesis
17%
Menstrual Cycle
17%
Drug Dose Regimen
17%
Subgroup Analysis
17%
Spontaneous Abortion
17%
In Vitro Fertilisation
17%
Plasminogen Activator Inhibitor-1
16%
Insulin Resistance
16%
Androstenedione
15%
Prospective Cohort Study
15%
